NCT03798704

Brief Summary

The aim of this study is to compare two different serological tests, IFA and LIAISON, for detection of Borrelia burgdorferi sensu lato IgM and IgG antibiodies in children with early disseminated Lyme borreliosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
349

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2018

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 10, 2019

Completed
19 days until next milestone

Study Start

First participant enrolled

January 29, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

April 30, 2021

Status Verified

April 1, 2021

Enrollment Period

1.9 years

First QC Date

December 17, 2018

Last Update Submit

April 29, 2021

Conditions

Keywords

Lyme diseaseIFALIAISONchildrenSlovenia

Outcome Measures

Primary Outcomes (1)

  • Sensitivity IFA vs. LIAISON

    LIAISON test (E/ml) is expected to be more sensitive than IFA (titer) in detection of Borrelial antibodies in children with early disseminated LB. In all patients both asseys (LIAISON and IFA) are going to be done from the same samples. The difference in the proportion of positive tests between the two assays will be statisticaly analyzed for IgM and IgG antibodies of each patient group. P values \< 0,05 will be interpreted as statistically significant. IFA: Titres \>256 in serum and \>4 in CSF will be considered positive. LIAISON values in serum: the values of IgM and IgG in serum \<18 in \<10 E/ml will be considered as negative, 18-22 and 10-15 E/ml will be considerd as border values and \>22 in \>15 E/ml will be considered as positive. LIAISON in cerebral fluid: the values of IgM in IgG in cerebral fluid \<2,5 and \<4,5 E/ml will be considered as negative, values 2,5-3,5 and 4,5-5,5 E/ml will be considered as border values and \>2,5 in \>5,5 E/ml will be considered as positive.

    2 years

Interventions

IFA, LIAISONDIAGNOSTIC_TEST

Comparison of two diagnostic serological tests - IFA and LIAISON.

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Younger then 18 years

Children younger than 18 years with early disseminated Lyme disease: * multiple erythema migrans * peripheral facial nerve palsy * lymphocytic meningitis

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

University clinical center

Ljubljana, Slovenia

Location

MeSH Terms

Conditions

Lyme Disease

Condition Hierarchy (Ancestors)

Gram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsBorrelia InfectionsSpirochaetales InfectionsTick-Borne DiseasesVector Borne Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
izr. prof. dr. Maja Arnez, dr. med

Study Record Dates

First Submitted

December 17, 2018

First Posted

January 10, 2019

Study Start

January 29, 2019

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

April 30, 2021

Record last verified: 2021-04

Locations